BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Central Pacific Financial
CPF
$1B
| $65.6M | ﹤0.01% |
4,090,034
-63,720
| -2% | -$1.01M |
|
|
SPPI
2102
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $65.5M | ﹤0.01% |
19,389,487
+1,102,094
| +6% | +$3.21M |
|
2103
Sociedad Química y Minera de Chile
SQM
$20.5B
| $65.3M | ﹤0.01% |
2,504,776
+2,016,565
| +413% | +$48.5M |
|
2104
Arcus Biosciences
RCUS
$3.65B
| $65.3M | ﹤0.01% |
2,639,092
-141,256
| -5% | -$3.81M |
|
|
BRSL
2105
Brightstar Lottery PLC
BRSL
$2.08B
| $65.3M | ﹤0.01% |
7,335,181
+4,782,092
| +187% | +$37.3M |
|
2106
Goosehead Insurance
GSHD
$2.32B
| $65.2M | ﹤0.01% |
867,679
+91,429
| +12% | +$5.3M |
|
|
KDMN
2107
DELISTED
Kadmon Holdings, Inc.
KDMN
| $65.2M | ﹤0.01% |
12,730,446
+693,110
| +6% | +$3.11M |
|
|
GTHX
2108
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $65.1M | ﹤0.01% |
2,683,923
+104,756
| +4% | +$1.73M |
|
|
EGIO
2109
DELISTED
Edgio, Inc. Common Stock
EGIO
| $64.6M | ﹤0.01% |
219,424
+12,674
| +6% | +$2.81M |
|
2110
TriCo Bancshares
TCBK
$1.83B
| $64.5M | ﹤0.01% |
2,118,954
-45,787
| -2% | -$1.31M |
|
|
TVRD
2111
Tvardi Therapeutics
TVRD
$22.1M
| $64.5M | ﹤0.01% |
104,760
+7,587
| +8% | +$4.19M |
|
|
ECHO
2112
EchoStar
ECHO
$25.5B
| $64.4M | ﹤0.01% |
2,304,961
+73,500
| +3% | +$2.23M |
|
2113
Brown-Forman Class A
BF.A
$13B
| $64.1M | ﹤0.01% |
1,113,563
-41,261
| -4% | -$2.41M |
|
2114
Kforce
KFRC
$1.04B
| $64.1M | ﹤0.01% |
2,189,982
+958
| +0% | +$27.9K |
|
|
HSII
2115
DELISTED
Heidrick & Struggles
HSII
| $63.9M | ﹤0.01% |
2,955,889
-8,362
| -0.3% | -$184K |
|
2116
Hawkins
HWKN
$2.7B
| $63.7M | ﹤0.01% |
2,991,794
-9,184
| -0.3% | -$174K |
|
2117
Camping World
CWH
$659M
| $63.5M | ﹤0.01% |
2,338,196
+122,128
| +6% | +$1.97M |
|
2118
Calix
CALX
$2.48B
| $63.4M | ﹤0.01% |
4,256,229
+42,732
| +1% | +$491K |
|
2119
Brookdale Senior Living
BKD
$3.02B
| $63.1M | ﹤0.01% |
21,406,724
+4,231,660
| +25% | +$13.7M |
|
|
API
2120
Agora
API
$398M
| $63.1M | ﹤0.01% |
+1,428,129
| New | +$67.4M |
|
2121
Comtech Telecommunications
CMTL
$52.1M
| $63M | ﹤0.01% |
3,728,352
+1,145
| +0% | +$19.4K |
|
2122
DMC Global
BOOM
$156M
| $62.9M | ﹤0.01% |
2,280,713
+155,875
| +7% | +$4.3M |
|
2123
Monarch Casino & Resort
MCRI
$2.21B
| $62.9M | ﹤0.01% |
1,845,609
+95,126
| +5% | +$3.15M |
|
2124
AngioDynamics
ANGO
$655M
| $62.7M | ﹤0.01% |
6,166,227
-30,328
| -0.5% | -$313K |
|
2125
Rocket Pharmaceuticals
RCKT
$378M
| $62.4M | ﹤0.01% |
2,982,896
+276,944
| +10% | +$4.99M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.